[Splanchnic vein thrombosis]. / Splanchnická zilní trombóza.
Vnitr Lek
; 64(3): 272-279, 2018.
Article
em Cs
| MEDLINE
| ID: mdl-29766730
ABSTRACT
Splanchnic vein thrombosis (SVT) represents an unusual manifestation of venous thromboembolism. The etiological factors for SVT can be divided into local and systemic, frequently found concurrently. SVT can be the first presenting symptom in myeloproliferative neoplasms. SVT puts the patients affected in jeopardy of developing the intestinal infarction, impairing the liver function and portal hypertension development with the risk of potentially life-threatening gastrointestinal bleeding. The current guidelines emphasise the role of anticoagulation in acute splanchnic thrombosis. Considering the potentially fatal complications it is necessary to tailor the anticoagulant treatment individually. The duration of anticoagulant therapy is strongly dependent upon the risk evaluation of thrombosis recurrence. The article deals with the causes, diagnostic methods and aspects influencing the therapeutic strategy.Key words anticoagulation - liver cirrhosis - portal hypertension - prothrombotic state - splanchnic vein thrombosis.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Trombose Venosa
/
Anticoagulantes
/
Transtornos Mieloproliferativos
Tipo de estudo:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Limite:
Humans
Idioma:
Cs
Ano de publicação:
2018
Tipo de documento:
Article